Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, Johansen OE, Woerle HJ, Broedl UC, Zinman B, EMPA-REG OUTCOME Investigators
As long as were in this high-trend environment, with all we do to try to mitigate that, I would expect were still going to be in a high-premium environment. Marrone added that while he expects increases in premiums to moderate, he had a cautious outlook on the near-term horizon
placebo in patients who were overweight or obese and showed sustained, clinically relevant weight loss and improvement in lipid parameters
Mean body weight reduction with liraglutide titrated up to 3.0 mg ranged from 2.3 to 12.3 kg, while patients on semaglutide up to 2.4 mg experienced a mean body weight reduction ranging from 8.2 to 15.8 kg
COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters